Doctors track COPD patients after switching to stronger inhaler
NCT ID NCT05915182
Summary
This study observed 212 adults in Greece with moderate to severe COPD who were newly prescribed a triple-combination inhaler (Trixeo Aerosphere™) as part of their regular care. The goal was to see how patients felt and functioned over one year after switching to this stronger medication and to understand why their doctors made the switch. Researchers collected information on breathing, quality of life, and treatment satisfaction during routine doctor visits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE (COPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alexandroupoli, 68100, Greece
-
Research Site
Athens, 11521, Greece
-
Research Site
Athens, 11527, Greece
-
Research Site
Athens, 12462, Greece
-
Research Site
Athens, 17562, Greece
-
Research Site
Corfu, 49100, Greece
-
Research Site
Crete, 71409, Greece
-
Research Site
Crete, 71500, Greece
-
Research Site
Crete, 73300, Greece
-
Research Site
Ioannina, 45500, Greece
-
Research Site
Larissa, 41110, Greece
-
Research Site
Pátrai, 26332, Greece
-
Research Site
Pátrai, 26504, Greece
-
Research Site
Thessaloniki, 56429, Greece
-
Research Site
Thessaloniki, 57010, Greece
Conditions
Explore the condition pages connected to this study.